Fate Therapeutics Inc (FATE)

SG&A Expense Growth

-7.99%

Quarterly · Period ending:

FATE logo

FATE SG&A Expense Growth

Latest reported-7.99%
FATE Quarterly SG&A Growth (QoQ) (0.00% → -7.99%)
High-resolution chart · PNG

FATE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Fate Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-7.9929%
-10.0234%
0.2538%
-7.0511%
-16.9026%
-56.5959%
52.5504%
20.5785%
-17.2812%
16.281%
-5.3462%
-16.2408%
3.0944%
1.6633%
0.1345%
5.9162%
-1.8851%
22.4728%
7.7491%
29.1749%
-2.656%
21.2062%
23.4942%
11.3021%
-2.9241%
15.8597%
5.1213%
20.4175%
-1.4953%
24.2164%
5.5379%
6.9444%
5.8824%
6.5012%
21.3773%
4.4586%
-11.9723%
23.7046%
-6.1279%
16.096%
-13.5665%
1.8395%
8.6772%
-12.6022%
-2.3948%
32.6275%
9.1387%
-8.1081%
-14.2029%
29.0754%
-5.4573%
32.6408%
15.0347%
1.0125%
48.7833%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.